Literature DB >> 6227277

Suppressor T-lymphocytes in multiple sclerosis: analysis of patients with acute relapsing and chronic progressive disease.

D W Paty, L Kastrukoff, N Morgan, L Hiob.   

Abstract

T cell-specific antigens as identified by the anti-Leu 1, anti-Leu 2a, and anti-Leu 3a monoclonal antibodies were quantitated in 31 normal control subjects, 21 adults with spinal cord injury, 58 patients with stable multiple sclerosis, 31 patients with chronic progressive multiple sclerosis, and 15 patients with multiple sclerosis in acute relapse. The only significant deviations from normal values were a slightly low mean T cell (Leu 1-positive) value in patients in acute relapse and a low suppressor T cell (Leu 2a-positive) mean value in patients with chronic progressive multiple sclerosis. We were unable to confirm previous studies using the OK series of monoclonal antibodies that reported low suppressor T cell levels (OKT5 and OKT8 positive) in patients with acute relapses. We suggest that modulation (a spontaneous or induced variability in the expression) of individual cell surface antigens may explain the differences seen between our study and other reported series.

Entities:  

Mesh:

Year:  1983        PMID: 6227277     DOI: 10.1002/ana.410140408

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  21 in total

1.  Serial studies of evoked potentials and circulating lymphocyte subsets for multiple sclerosis: attempts to monitor progress.

Authors:  H M Chapel; M Small; S Gregory; W B Matthews
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

2.  Cell count and ratio of helper/inducer to suppressor/cytotoxic T-cells in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  H W Kölmel; C Sudau
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

3.  Dual labelling of circulating CD8 cells in patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

4.  Determination of activated lymphocytes in peripheral blood of patients with multiple sclerosis.

Authors:  A D Crockard; T A McNeill; J McKirgan; S A Hawkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

5.  Suppressor T cell changes in active multiple sclerosis: analysis with three different monoclonal antibodies.

Authors:  A J Thompson; J Brazil; E A Martin; M Hutchinson; C A Whelan; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-10       Impact factor: 10.154

6.  Factors influencing circulating OKT8 cell phenotypes in patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; J Dyas; J A Munro; K I Welsh; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

7.  Proteolytic enzyme activities of macrophages and lymphocytes in neurological diseases.

Authors:  I Goto; N Shinno; Y Kuroiwa
Journal:  J Neurol       Date:  1986-11       Impact factor: 4.849

8.  Cerebrospinal fluid lymphocyte subpopulations in multiple sclerosis.

Authors:  M G Marrosu; C Cianchetti; M G Ennas
Journal:  Ital J Neurol Sci       Date:  1986-02

9.  Circulating CD3+ CD4+ CD8+ T lymphocytes in multiple sclerosis.

Authors:  F E Munschauer; C Stewart; L Jacobs; S Kaba; Z Ghorishi; S J Greenberg; D Cookfair
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

10.  Lymphocyte activating factor activity in the serum and cerebrospinal fluid of patients with multiple sclerosis.

Authors:  D Donati; P Annunziata; G C Guazzi; D Boraschi; A Tagliabue
Journal:  Ital J Neurol Sci       Date:  1990-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.